Our DigiLum™ product is protected under an IP portfolio that includes both internal innovations and externally licensed IP. Lumeda has secured a globally exclusive license to patents from Roswell Park Cancer Institute covering novel medical devices and light dosimetry methods used in the DigiLum™ system.

The company continues to generate patent applications with recent patents issued that cover optical devices, instrumentation, and machine-learning algorithms incorporated in the DigiLum™ system, as well as use of the system in minimally invasive procedures and other settings.